Intraperitoneal chromic phosphate in ovarian cancer: Risks and benefits
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 32 (3) , 314-318
- https://doi.org/10.1016/0090-8258(89)90631-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Second-look laparotomy after chemotherapy in the management of ovarian malignancyAmerican Journal of Obstetrics and Gynecology, 1985
- Complications from intraperitoneal radioactive phosphorus in ovarian malignanciesGynecologic Oncology, 1985
- Microscopic disease at second-look laparotomy in advanced ovarian cancerCancer, 1985
- Whole-body distribution of radioactivity after intraperitoneal administration of32P colloidsThe British Journal of Radiology, 1984
- Radiotherapy in Epithelial Ovarian CancerObstetrics & Gynecology, 1983
- Intraperitoneal chromic phosphate in peritoneoscopically confirmed Stage I ovarian adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1982
- Second-look operations in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1980
- Acute Leukemia after Alkylating-Agent Therapy of Ovarian CancerNew England Journal of Medicine, 1977
- Carcinoma of the ovary: The adjunctive use of irradiationGynecologic Oncology, 1975
- Radiation therapy in the treatment of carcinoma of the ovaryCancer, 1972